Thursday, June 08, 2023
ACROBiosystems is a reputable company in the field of cell and gene therapy (CGT), providing a comprehensive range of services to support the commercialization of these advanced therapies. CGT involves enhancing the immune system to combat cancer by infusing stem cells or modified immune cells, and manufacturing cell therapies presents significant challenges.
To address the manufacturing needs of cell therapies, ACROBiosystems now offers global custom protein services that adhere to Good Manufacturing Practice (GMP) standards. These services are specifically designed to supply raw materials or ancillaries required in the production of CGT. With a decade of experience in protein development and manufacturing, ACROBiosystems has successfully developed over 5,000 recombinant protein products.
The company's product catalog includes a diverse range of growth factors for cell culture, available in different quality grades, including RUO, Premium, and GMP. These products encompass the entire drug development process, from initial discovery to eventual commercialization, ensuring that customers have access to the necessary reagents at every stage.
ACROBiosystems recognizes that each customer may have unique requirements, and therefore, they offer an extensive portfolio of custom solutions. This includes multiple protein expression systems, such as mammalian, prokaryotic, insect, and yeast systems, along with tailored purification methods, protein labeling, and other modifications, all designed to meet the specific needs of individual clients.
To facilitate the transition from preclinical to clinical research, ACROBiosystems provides superior quality reagents that serve as a representative sample of GMP-grade reagent performance. Additionally, they offer a "refresh" service to efficiently convert non-GMP compliant reagents into GMP quality products. The company's services encompass the entire development process, including specific protein design, gene synthesis, vector construction, protein expression, and scale production.
ACROBiosystems is dedicated to supplying high-quality reagents for clinical research and commercial production on a global scale. To fulfill this commitment, they have established a spacious GMP-quality protein manufacturing facility spanning over 180,000 square feet. This facility is solely dedicated to producing GMP quality products, including proteins, enzymes, and antibodies, ensuring the stringent standards required for clinical research and commercialization are met.
